The Entero Healthcare Solutions date has been confirmed from February 9, 2024 and closes on February 13, 2024.
Entero Healthcare Solutions Developers IPO is a fixed price issue of Rs 1,600.00 crores. The price band is set at ₹1195 to ₹1258 per share. The minimum lot size for an application is 11 Shares. The minimum amount of investment required by retail investors is ₹13,838. The minimum lot size investment for sNII is 15 lots (165 shares), amounting to ₹207,570, and for bNII, it is 73 lots (803 shares), amounting to ₹1,010,174.
Start your investing journey today. How do you open your own demat account for free?
Bidding Dates
Feb 9-13
Price Range
₹1195 to ₹1258 per share
Face Value
₹10 per share
GMP
₹2
Entero Healthcare Solutions IPO GMP
The Entero Healthcare Solutions IPO GMP is ₹2.
IPO Overview
The Entero Healthcare Solutions IPO is a book-built issuance for Rs 1,600.00 crore. The offering consists of a fresh issue of 0.79 crore shares valued at Rs 1,000.00 crores and an offer for sale of 0.48 crore shares valued at Rs 600.00 crores. Entero Healthcare Solutions’ initial public offering (IPO) begins on February 9, 2024 and ends on February 13, 2024. The allotment for Entero Healthcare Solutions’ IPO is expected to be finalised on Wednesday, February 14, 2024. The Entero Healthcare Solutions IPO will list on the BSE and NSE, with a tentative listing date of Friday, February 16, 2024.
Entero Healthcare Solutions’ IPO price range is ₹1195 to ₹1258 per share. The minimum lot size for an application is 11 shares. The minimum investment for retail investors is ₹13,838. The minimum lot size investment for sNII is 15 lots (165 shares) for ₹207,570, while for bNII it is 73 lots (803 shares) worth ₹1,010,174.
Entero Healthcare Solutions IPO Details
| IPO Date | February 9, 2024 to February 13, 2024 |
| Listing Date | [.] |
| Face Value | ₹10 per share |
| Price Band | ₹1195 to ₹1258 per share |
| Lot Size | 11 Shares |
| Total Issue Size | 12,718,600 shares (aggregating up to ₹1,600.00 Cr) |
| Fresh Issue | 7,949,125 shares (aggregating up to ₹1,000.00 Cr) |
| Offer for Sale | 4,769,475 shares of ₹10 (aggregating up to ₹600.00 Cr) |
| Employee Discount | Rs 119 per share |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE, NSE |
| Share holding pre issue | 16,066,886 |
| Share holding post issue | 24,016,011 |
Entero Healthcare Solutions Limited Financial Information
| Period Ended | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
| Assets | 1,308.73 | 1,125.98 | 833.79 |
| Revenue | 3,305.72 | 2,526.55 | 1,783.67 |
| Profit After Tax | -11.10 | -29.44 | -15.35 |
| Net Worth | 597.66 | 563.22 | 487.06 |
| Total Borrowing | 373.52 | 285.03 | 141.70 |
| Amount in ₹ Crore | |||
Entero Healthcare Solutions IPO Timeline
| IPO Open Date | Friday, February 9, 2024 |
| IPO Close Date | Tuesday, February 13, 2024 |
| Basis of Allotment | Wednesday, February 14, 2024 |
| Initiation of Refunds | Thursday, February 15, 2024 |
| Credit of Shares to Demat | Thursday, February 15, 2024 |
| Listing Date | Friday, February 16, 2024 |
| Cut-off time for UPI mandate confirmation | 5 PM on February 13, 2024 |
Company Profile
Entero Healthcare Solutions Limited, founded in 2018, is a healthcare goods distributor in India. The company’s technology-driven platform offers healthcare product distribution services to pharmacies, hospitals, and clinics across India. In fiscal years 2021, 2022, and 2023, the company served over 39,500, 64,200, and 81,400 retail consumers. In addition, they served over 1,600, 2,500, and 3,400 hospital patients throughout the same time period. Entero Healthcare Solutions has agreements with over 1,900 healthcare product manufacturers, granting them access
to over 64,500 product stock-keeping units as of March 31, 2023. As of March 31, 2023, the corporation operates 73 warehouses in 37 cities spanning 19 states and union territories, serving approximately 81,400 pharmacies and 3,400 hospitals in 495 districts. This offers tremendous access to healthcare product producers. As of March 31, 2023, the company employed a total of 3014 workers across several divisions.
Registrar Info
| Name | Link Intime India Private Ltd |
| Phone number | +91-22-4918 6270 |
| Email ID | enterohealthcare.ipo@linkintime.co.in |
| Website | linkintime.co.in |
Contact Details
| Name | Entero Healthcare Solutions Limited |
| Phone number | +91 22-69019100 |
| Email ID | jayant.prakash@enterohealthcare.com |
| Website | enterohealthcare.com |
IPO Strenghts
- Experienced promoters and a competent management team.
- Well-established relationships with a loyal customer base.
- Access to markets worldwide, enabling global reach.
IPO Weakness
- Heavy reliance on customers based in the United States.
- Need to adhere to multiple laws and regulations in these countries to ensure compliance.
- Competition from other players in the market.
